AK2 inhibitors are a group of chemical compounds that have been that hinder the activity of adenylate kinase 2 (AK2), an enzyme with a pivotal role in cellular bioenergetics. Within the intricate landscape of cellular metabolism, adenylate kinases serve as indispensable players, facilitating the interconversion of adenine nucleotides. AK2, situated predominantly within the mitochondria, holds the responsibility of phosphorylating adenosine diphosphate (ADP) into adenosine triphosphate (ATP), a molecule that fuels an array of essential cellular functions. The concept behind AK2 inhibitors lies in their strategic interference with the enzyme's catalytic cycle. These inhibitors typically operate by binding to specific sites on the enzyme, potentially obstructing the substrate binding site or impeding the catalytic mechanism itself. This deliberate disruption has the intended consequence of impeding the normal enzymatic process of ADP phosphorylation, thereby modulating the cellular ATP/ADP ratio.
The chemical structures of AK2 inhibitors showcase an assortment of diverse scaffolds, exemplified by compounds like benzothiazole derivatives, oxalylamino-benzoic acid derivatives, and triphenylmethane derivatives. Each inhibitor's distinct structural composition contributes to its capacity for selectively targeting AK2 while avoiding unwanted interactions with other cellular components. Interestingly, while AK2 inhibitors are primarily associated with their involvement in energy metabolism, recent scientific explorations suggest that their impact might extend beyond this core function. Intriguing connections between mitochondrial dysfunction and broader cellular processes have raised the prospect of AK2 playing roles beyond the traditional understanding of energy homeostasis. Given the intricate web of biochemical pathways in which AK2 is embedded, the investigation into AK2 inhibitors transcends their immediate relevance to energy production. By shedding light on the intricacies of AK2 inhibition, researchers not only advance their comprehension of cellular energetics but also uncover potential crossroads between energy metabolism and other cellular phenomena.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium dichloroacetate | 2156-56-1 | sc-203275 sc-203275A | 10 g 50 g | $55.00 $209.00 | 6 | |
Although primarily known for its effects on the pyruvate dehydrogenase complex, DCA has also been reported to inhibit AK2 | ||||||
Diphenyleneiodonium chloride | 4673-26-1 | sc-202584E sc-202584 sc-202584D sc-202584A sc-202584B sc-202584C | 10 mg 25 mg 50 mg 100 mg 250 mg 500 mg | $151.00 $136.00 $317.00 $405.00 $944.00 $1837.00 | 24 | |
DPI is a known inhibitor of flavoproteins and has been reported to inhibit AK2 activity. It is often used as a tool compound in research to study various cellular processes. | ||||||
(+)-α-Tocopherol | 59-02-9 | sc-214454 sc-214454A sc-214454B sc-214454C | 10 g 25 g 100 g 1 kg | $43.00 $62.00 $141.00 $430.00 | ||
Certain forms of vitamin E, such as δ-tocotrienol, have been reported to inhibit AK2 activity. Vitamin E compounds are known for their antioxidant properties. | ||||||